Dercum’s disease is a rare pain syndrome characterized by chronically painful growths of fatty tissue or lipomas. These lipomas most commonly occur in the upper arms, upper legs, and trunk region. According to a report by the American Society of Interventional Pain Physicians in 2017, although women are most commonly affected by this condition, about 16% of the reported cases were in men. The common symptoms of this condition include painful fatty lipomas covering the body, obesity majorly in women in menopausal age, weakness, memory issues, elevated heart rate, joint aches, depression, and dementia. Currently, there is no cure for this condition and it is treated symptomatically with surgery, alternative therapies, and with medications such as non-steroidal anti-inflammatory drugs, diuretics, among others.
The global Dercum’s Disease Market Size is anticipated to be growing due to factors such increasing expenditures in the healthcare sector in the developed as well as developing economies, growing occurrences of lipomas, increasing prevalence of rare diseases, and rising research and development activities. On the other hand, lack of awareness about the disease is likely to hamper the growth of the market over the forecast period.
On the regional basis, the dercum’s disease market in the Americas is segmented into two major regions, i.e., North America and South America. The North American region is likely to hold the major share in the global dercum’s disease market, owing to the owing to the presence of a well-established healthcare segment, and increasing disposable income. Moreover, increasing funding for research and development by government fuels the market growth in this region.
The global dercum’s disease market has been segmented into dercums disease treatment , distribution channel, and end user.
Dercum's Disease Market Key Players
Pfizer, Inc., Abbvie, Inc., Johnson & Johnson, GlaxoSmithKline Plc, Merck & Co., Inc., Novartis, F. Hoffman, La Roche AG, Eli Lily and Company, AstraZeneca PLC, Amgen, Valeant Pharmaceuticals, Syneron Medical, St. Jude Medical Inc. and Alimed, Inc. are some major players in the global dercum’s disease market.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York, New York 10013,
United States of America
+1 646 845 9312
Email: [email protected]
Orbis Research has announced the addition of the “Global Skin Diagnostic Equipment Market Size, Status and Forecast 2019-2025” to store by company, by country, and by application/type for the competitive landscape analysis.The Global Skin Diagnostic Equipment Market status, future forecast, growth opportunity, key market and key players.
The study objectives are to present the Skin Diagnostic Equipment development in United States, Europe and China.This report studies the global market size of Skin Diagnostic Equipment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Skin Diagnostic Equipment in these regions.
This research report categorizes the global Skin Diagnostic Equipment market by top players/brands, region, type and end user.
This report also studies the global Skin Diagnostic Equipment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.Request a sample of this report @ http://orbisresearch.com/contacts/request-sample/2715840 .The following manufacturers are covered in this report, with sales, revenue, market share for each company: Heine Mela Sciences Michelson Diagnostics Welch Allyn Market size by Product Portable Stationary Market size by End User Household Hospital Clinic OthersIf enquiry before buying this report @ http://orbisresearch.com/contacts/enquiry-before-buying/2715840 .About Us: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements.
We have vast database of reports from the leading publishers and authors across the globe.
We specialize in delivering customized reports as per the requirements of our clients.
The global market for chloroxylenol (PCMX, CAS 88-04-0) will grow at a CAGR of 6.8% by 2022, according to a new report published by Gen Consulting Company.
The report segments the market and forecasts its size, by volume and value, on the basis of application (healthcare, personal care & cosmetics, industrial), and by geography (North America, Europe, Asia-Pacific, MEA and South America).
The study then describes the drivers and restraints for the chloroxylenol market along with the impact they have on the demand over the forecast period.
Download Free Sample Report @ https://www.radiantinsights.com/research/global-chloroxylenol-market-outlook-2017-2022/request-sample The report has been prepared based on the synthesis, analysis, and interpretation of information about the global chloroxylenol market collected from specialized sources.
The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players.
Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile.
